Comparison of haemoglobin assessments by HemoCue and two automated haematology analysers in young Laotian children. by Hinnouho, Guy-Marino et al.
UC Davis
UC Davis Previously Published Works
Title
Comparison of haemoglobin assessments by HemoCue and two automated haematology 
analysers in young Laotian children.
Permalink
https://escholarship.org/uc/item/95d6k168
Journal
Journal of clinical pathology, 71(6)
ISSN
0021-9746
Authors
Hinnouho, Guy-Marino
Barffour, Maxwell A
Wessells, K Ryan
et al.
Publication Date
2018-06-01
DOI
10.1136/jclinpath-2017-204786
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
532  Hinnouho G-M, et al. J Clin Pathol 2018;71:532–538. doi:10.1136/jclinpath-2017-204786
Comparison of haemoglobin assessments by 
HemoCue and two automated haematology analysers 
in young Laotian children
Guy-Marino Hinnouho,1 Maxwell A Barffour,1 K Ryan Wessells,1 Kenneth H Brown,1,2 
Sengchanh Kounnavong,3 Bigphone Chanhthavong,3 Kethmany Ratsavong,3 
Chidchamai Kewcharoenwong,4 Sonja Y Hess1
Original article
To cite: Hinnouho G-M, 
Barffour MA, Wessells KR, 
et al. J Clin Pathol 
2018;71:532–538.
 ► Additional material is 
published online only. To view 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
jclinpath- 2017- 204786).
1Department of Nutrition, 
Program in International and 
Community Nutrition, University 
of California, Davis, California, 
USA
2Nutrition and Global 
Development, Bill & Melinda 
Gates Foundation, Seattle, 
Washington, USA
3National Institute of Public 
Health, Vientiane, Laos
4Faculty of Associated Medical 
Sciences, Centre for Research 
and Development of Medical 
Diagnostic Laboratories, Khon 
Kaen University, Khon Kaen, 
Thailand
Correspondence to
Dr Guy-Marino Hinnouho, 
Program in International 
and Community Nutrition, 
Department of Nutrition, 
University of California, One 
Shields Avenue, Davis, CA 
95616, USA;  gmhinnouho@ 
ucdavis. edu
Received 11 September 2017
Accepted 14 November 2017
Published Online First 
2 December 2017
AbsTrACT 
background Haemoglobin (Hb) assessment by 
Hemocue is used widely for anaemia screening in both 
adults and children. However, few studies have compared 
the diagnostic accuracy of Hemocue with an automated 
haematology analyser in young children.
Aim To compare Hb concentrations by Hemocue Hb301 
and two automated haematology analysers in young 
children in rural communities of Lao PDR.
Methods Capillary blood was collected from 6-month-
old to 23-month-old children (n=1487) for determination 
of Hb concentration by Hemocue Hb301. On the same 
day, venous blood was collected for complete blood 
count using one of two haematology analysers (XT-
1800i, Sysmex, and BC-3000Plus, Mindray Medical 
International). In a subsample of children (n=129), 
venous Hb was also measured by HemoCue Hb301. 
Agreement between the two methods was estimated 
using Bland-Altman plots.
results Mean capillary Hb by Hemocue was 
significantly higher than mean venous Hb by 
haematology analysers combined (108.4±10.3 g/L vs 
102.3±13.1 g/L; P<0.001), resulting in a significantly 
lower anaemia prevalence (Hb <110 g/L) by Hemocue 
(53.7% vs 73.9%; P<0.001). The Bland-Altman 
assessment of agreement showed a bias of 6.1 g/L 
and limits of agreement were −11.5 g/L to 23.7 g/L. 
Mean venous Hb concentration by Hemocue Hb301 
(113.6±14.0 g/L) was significantly higher than mean 
capillary Hb concentration by Hemocue Hb301 
(110.0±10.7; P=0.03 g/L), which in turn was significantly 
higher than mean venous Hb concentration by the 
Mindray BC-3000Plus (102.3±17.4 g/L).
Conclusion Capillary and venous Hb concentrations 
assessed by Hemocue Hb301 showed poor agreement 
compared with venous Hb by automated haematology 
analysers, resulting in significantly different anaemia 
prevalences.
InTrOduCTIOn
Anaemia is a major public health concern, 
affecting 43% of young children and 38% of preg-
nant women globally.1 Primary causes of anaemia 
include micronutrient deficiencies, parasitic 
infections, such as malaria and hookworm, and 
inherited haemoglobin (Hb) disorders.2–5Anaemia 
has several negative consequences on health and 
may cause low birth weight, preterm birth and 
perinatal, neonatal and maternal mortality during 
pregnancy.6 In addition, iron deficiency anaemia 
has been linked with poor psychomotor devel-
opment of children and reduced physical perfor-
mance in adults.7
Hb concentration is the most commonly used 
indicator of anaemia at the individual and popula-
tion level8 and is used for both screening and eval-
uating the impact of intervention programmes.9 
Numerous methods are available for measuring 
Hb concentration,10–14 of which the cyanmethemo-
globin method is considered the reference method 
by the International Committee for Standardiza-
tion in Hematology10 and is recommended by the 
World Health Organization (WHO).15 However, 
this analytical method is fairly time consuming and 
therefore relatively costly.16 In clinical laboratory 
settings, Hb concentration is generally assessed by 
automated haematology analysers,12 13 which are 
very reliable and accurate, but expensive and not 
transportable to the field. In field settings where 
resources are limited, the HemoCue device has 
been used extensively because it is portable, easy 
to use and relatively inexpensive. Moreover, the 
HemoCue device requires only a small drop of 
capillary or venous blood and provides an imme-
diate numerical Hb value.17
Multiple studies have examined the accuracy 
and precision of HemoCue results compared with 
automated haematology analysers in different 
adult populations, and findings from these studies 
are mixed.18–25 Several factors may explain the 
discrepancy between studies, including measure-
ment errors, blood sampling site (capillary vs 
venous blood),26 analytical setting (laboratory 
vs field) and population characteristics (healthy 
adults, pregnant women, blood donors, ill 
patients, etc).
To date, few published data exist on the accu-
racy of HemoCue versus an automated haema-
tology analyser in children both in laboratory27–29 
and field settings.25 30 To our knowledge, only 
one study included very young children.28 
This study, implemented in 11-month-old to 
36-month-old children in immunisation clinics 
in east London, found that Hb concentrations 
measured by HemoCue were consistently greater 
than Hb levels measured by a haematology anal-
yser (Coulter counter). Because the anaemia prev-
alence of children under 5 years of age is assessed 
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by HemoCue in most national surveys and considering the 
reported inconsistency of the relative accuracy and reliability 
of this method,7 17 the present study aimed to: (1) compare Hb 
concentrations measured by HemoCue Hb301 and automated 
haematology analysers in young children in rural communi-
ties of Lao PDR, (2) compare the estimated anaemia preva-
lence derived from these two methods, (3) determine the 
accuracy of HemoCue Hb301 using both venous and capillary 
blood samples compared with that of an automated haema-
tology analyser using venous blood and (4) compare the Hb 
measurements provided by the three different project-owned 
HemoCue Hb301 devices.
MeThOds
study population
Data were drawn from the Lao Zinc Study, a community-based 
randomised controlled trial implemented in rural commu-
nities of Khammouane Province in Lao PDR (registered at 
www. ClinicalTrials. gov; NCT02428647). The study protocol 
and the consent procedure were approved by the National 
Ethics Committee for Health Research (Lao PDR), Institu-
tional Review Board of the University of California, Davis 
(USA), and the Khon Kaen University Ethics Committee in 
Health Research (Thailand). Prior to any examination, written 
informed consent (documented by either a signature or a 
fingerprint in the presence of a neutral witness) was obtained 
from one of the child’s primary caregivers (mother, father or 
legal guardian). In a first set of analyses of the present paper, 
we used data from a convenience subsample of 1487 children, 
6–23 months of age at baseline whose Hb concentrations were 
assessed during study enrolment (September 2015 through 
August 2016; objectives 1 and 2). All data available were used 
for the present methodological comparison, which was consid-
ered adequate based on sample size recommendations for the 
Bland-Altman method by Lu et al.31 Retrospective sample size 
calculation showed that our sample size of n=1487 allowed 
us to estimate the bias with a 95% CI of 0.91 g/L and the 
Bland-Altman limits of agreement with a 95% CI of 1.6 g/L. 
For logistical reasons, the venous blood samples were anal-
ysed by two different haematology analysers, as described in 
more detail below. In a second set of analyses involving 129 
children, 15–32 months of age, we compared venous and 
capillary Hb concentrations measured during the endline 
assessment (January through March 2017; objective 3). In a 
third set of analyses involving 29 children, 15–32 months of 
age, we compared the Hb measurements by each of the three 
project-owned HemoCue Hb301 devices (November 2016; 
objective 4).
estimation of hb concentration
Non-fasting capillary and venous blood samples were collected 
within a few minutes of each other by trained phlebotomists, 
with the child in a seated position. Blood was drawn from the 
left side of the body whenever possible, and the sampling sites 
were cleaned with alcohol and left to air dry for a few seconds.
For capillary blood collection, the tip of the left middle finger 
was pricked with a lancet (Haemolancet Plus, HTL-STREFA, 
Poland), and the first drop of blood was wiped away with 
cotton. The fingertip of the left middle finger was used when-
ever possible because previous studies have reported a large 
within-subject variation in Hb concentration from the left to 
the right hand.9 A standard Hb301 microcuvette was used to 
collect the second drop of blood, and the cuvette was then 
wiped on the sides to remove any excess blood and imme-
diately inserted into the HemoCue Hb301 device (HemoCue 
AB, Angelholm, Sweden) for analysis. The HemoCue Hb301 
system determines the Hb concentration by measuring the 
absorbance of whole blood at an Hb/HbO2 isosbestic point. 
The device uses a double wavelength measuring method, 
506 nm and 880 nm, for compensation of turbidity.32 The 
results are displayed numerically in g/dL at the time of the 
measurement. In the present study, Hb results were recorded 
on an electronic device and manually in a notebook.
Venous blood was drawn from an antecubital, dorsal meta-
carpal or great saphenous vein into an EDTA tube (S-Mon-
ovette (K3 EDTA), Sarstedt AG & Co, Nümbrecht, Germany) 
from children who were not acutely ill with fever or reported 
diarrhoea. Right after collection, the tube was gently 
inverted 8–10 times and placed into a cold box at 4°C–8°C. 
The sample was transported the same day either to Nakhon 
Phanom Hospital, Thailand, or to the project field labora-
tory in Nongbok, Lao PDR. A complete blood count (CBC) 
was performed to estimate Hb concentrations using one of 
two automated haematology analysers: XT-1800i by Sysmex 
(n=633; at the Nakhon Phanom Hospital, Thailand) or 
BC-3000Plus by Mindray Medical International Ltd (n=854; 
at the project field laboratory, Nongbok, Lao PDR) for 
different aspects of the Lao Zinc Study. Using a unique diode 
laser bench, the Sysmex XT-1800i fluorescent flow cytometry 
uses a cyanide-free, sodium lauryl sulfate method and provides 
the sensitivity needed for measuring and differentiating cell 
types in whole blood and body fluid samples. Using a cyanide-
free reagent, the BC-3000Plus uses a colorimetric method 
to determine Hb concentrations. Hb measurements with the 
HemoCue Hb301 and the two automated haematology anal-
ysers were performed in accordance with the manufacturers’ 
operating manual.
For objective 3, venous Hb was measured using the 
HemoCue Hb301 device in a subsample of children to explore 
the differences between venous and capillary Hb concentra-
tions by the HemoCue Hb301 device. After gently inverting 
the EDTA tube 8–10 times, approximately 50 µl of whole 
blood was pipetted and placed on a microscopic slide. The 
blood drop was subsequently aspirated into a standard Hb301 
microcuvette and immediately inserted into the HemoCue 
Hb301 device to determine the venous Hb concentration.
To compare the Hb measurements provided by the different 
project-owned HemoCue Hb301 devices (objective 4), venous 
Hb was measured in a subsample of children (n=29), using 
three different devices. For each measurement, approximately 
50 µl of whole venous blood collected in an EDTA tube was 
placed on a microscopic slide and aspirated into a standard 
Hb301 microcuvette. A new blood drop was placed on a new 
microscopic slide for each HemoCue device.
Of the three different HemoCue Hb301 devices, the 
HemoCue Hb301 #1 and #2 were used in the field for routine 
capillary Hb concentration determinations for the main trial 
(objectives 1 and 2). HemoCue Hb301 #1 was used in the 
substudy of the 129 children (objective 3). HemoCue Hb301 
#3 was a back-up device, kept in the laboratory and was only 
used for the HemoCue comparison substudy (objective 4).
Quality control
Quality control checks were performed weekly for the 
HemoCue Hb301 devices (quality control checks for HemoCue 
Hb301 #3 were performed weekly only when the substudy 
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was implemented), weekly for the project-owned BC-3000Plus 
haematology analyser and daily for the XT-1800i haematology 
analyser by Sysmex at the Nakhon Phanom Hospital using 
the CBC-3D haematology control and a commercial control 
sample from Meditop Company, respectively. For external 
quality control, the hospital-based haematology analyser was 
also qualified by the External Quality Assessment Schemes in 
Clinical Microscopy from the Faculty of Medical Technology, 
Mahidol University, and by the Bureau of Laboratory Quality 
Standards, Ministry of Public Health, Thailand.
The Eurotrol Hb301 Control (levels 1 and 2) was used to 
verify the precision and accuracy of the HemoCue Hb301 
devices. The expected Hb values provided by the manufac-
turer were 71.0±8.0 and 130.0±12.0 g/L for levels 1 and 2, 
respectively.
statistical analysis
Data are presented as mean±SD or percentage when appro-
priate. Results of the automated haematology analysers were 
analysed combined and individually, as described in more 
detail below. Paired t-tests and McNemar tests were used to 
compare the difference between mean Hb concentrations and 
the anaemia prevalences, respectively, between the different 
methods of assessment. Analysis of variance followed by Bonfer-
roni corrected post hoc pairwise tests was used to compare the 
average bias between age groups. The correlation between the 
HemoCue Hb301 and the automated haematology analysers 
was plotted graphically to assess a possible linear association 
between the Hb values estimated by the two methods,33 and the 
Pearson’s correlation coefficient (rp) was calculated.
The prevalence of anaemia was determined using the Hb 
cut-off for children 6–59 months of age (Hb <110 g/L).8 The 
automated haematology analysers were considered the refer-
ence method against which the sensitivity and specificity of the 
HemoCue Hb301 were determined.
The concordance correlation coefficient (ρc) or Lin’s coef-
ficient,34 which combines measures of both precision and 
accuracy, was used to determine whether the observed data 
significantly deviated from the line of perfect concordance (ie, 
the line at 45 degrees). The bias and limits of agreement between 
the HemoCue Hb301 and the automated haematology analysers 
were estimated using Bland-Altman plots.35
Several complementary analyses were undertaken to assess 
the robustness of our findings. First, we repeated the same 
analyses with each automated analyser individually to assess 
the accuracy of the HemoCue Hb301 device against each auto-
mated analyser. It is important to note that, for this analysis, 
each comparison was done in a different subgroup of children. 
Second, we repeated the main analyses by age group (6–11, 
12–17 and 18–24 months) to explore whether the accuracy of 
the HemoCue Hb301 device differed by age group. Third, in a 
subsample of 129 children, we measured both venous Hb and 
capillary Hb using the HemoCue Hb301 and venous Hb using 
the automated haematology analyser at the field site (Mindray 
BC-3000Plus). Finally, we compared the Hb measurements 
provided by the different project owned HemoCue Hb301 
devices using venous blood of 29 children.
Analyses were undertaken using Stata 14 (StataCorp 2015, 
College Station, Texas, USA). Reported P values are two-tailed, 
and P values <0.05 were considered to be statistically significant.
resulTs
Capillary hb concentration by hemoCue hb301 versus venous 
hb concentration by two automated analysers combined
A total of 1487 children were included in this set of analyses. 
Their mean age±SD was 14.7±5.1 months, and 48.7% were 
female. Of these children, 35.2% (n=523) were 6–11 months, 
33.8% (n=502) were 12–17 months and 31.1% (n=462) were 
18–24 months.
The mean capillary Hb value obtained by HemoCue 
Hb301 was significantly greater than the mean venous Hb 
value obtained by the two automated haematology analysers 
combined (108.4±10.3 g/L vs 102.3±13.1 g/L; P<0.001; 
table 1). Accordingly, the prevalence of anaemia in the study 
population was significantly lower using the HemoCue Hb301 
device than the automated haematology analysers combined 
(53.7% vs 73.9%; P<0.001).
The sensitivity and specificity of the HemoCue Hb301 
compared with the two automated haematology analysers 
combined were 68.7% and 85.8%, respectively, suggesting 
that the two methods agreed better in non-anaemic chil-
dren (table 1). The two methods agreed in 71.9% of cases. 
A linear regression showed a strong correlation between the 
two methods (correlation coefficient rp=0.73; P<0.001). The 
concordance correlation coefficient was ρc=0.63 (P<0.001) 
and the reduced major axis and the line of perfect concor-
dance were not aligned (figure 1). Compared with venous Hb 
concentrations measured by the two automated haematology 
analysers, the HemoCue Hb301 device appears to overes-
timate capillary Hb concentrations at lower Hb levels. The 
Bland-Altman plot revealed an overall bias of 6.1 g/L and the 
limits of agreement (from −11.5 to 23.7 g/L) indicated that 
the two methods did not have good agreement (figure 2).
Results of analyses with the automated haematology analysers 
considered individually showed similar trends (online supple-
mentary table S1 and figures S1 and S2). Mean capillary 
Hb by Hemocue Hb301 was significantly higher than mean 
Hb obtained by both the Sysmex XT-1800 (110.7±9.7 g/L 
vs107.4±12.5 g/L; P<0.001) and the Mindray BC-3000Plus 
(106.7±10.4 g/L vs 98.4±12.2 g/L; P<0.001). Sensitivity, 
specificity and agreement of Hemocue Hb301 were slightly 
better with the Sysmex XT-1800i haematology analyser.
The mean capillary Hb obtained by HemoCue Hb301 was 
significantly greater than the mean venous Hb obtained by 
the two automated haematology analysers combined in all 
three age groups (all P<0.0001), but the difference between 
methods was similar in 12-month to 17-month and 18-month 
to 24-month children (5.9 g/L vs5.0 g/L; P=0.33), but 
Table 1 Haemoglobin concentration and anaemia prevalence in 
young Laotian children (n=1487) using two different methods of 
assessment
hemocue 
hb301
Automated 
haematology 
analysers combined* P value
Haemoglobin concentration, g/L
Mean±SD 108.4±10.3 102.3±13.1 <0.0001
Range 70–141 34–178
SE 0.3 0.3
Anaemia prevalence, n (%) 799 (53.7) 1099 (73.9) <0.0001
Sensitivity of Hemocue Hb301 (%) 68.7 Ref
Specificity of Hemocue Hb301 (%) 85.8 Ref
Agreement of the two methods 
(%)
71.9
*XT-1800i by Sysmex and BC-3000Plus by Mindray Medical International.
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significantly lower than that of children 6–11 months of age 
(5.9 g/L vs 7.3 g/L; P=0.036 and 5.0 g/L vs 7.3 g/L: P<0.003, 
respectively) (online supplementary table S2). Regardless of 
the age group, the box plots comparing the distribution of Hb 
levels by age group using the two methods (online supplemen-
tary figure S3) show a narrower range with HemoCue Hb301 
compared with those with automated haematology analysers 
combined.
hb concentration in capillary and venous blood by hemoCue 
hb301 versus venous blood by Mindray bC-3000Plus
Mean venous Hb concentration by Hemocue Hb301 was 
significantly higher than mean capillary Hb concentration by 
Hemocue Hb301, which in turn was significantly higher than 
mean venous Hb concentration by the Mindray BC-3000Plus 
(113.6±14.0, 111.7±10.7 and 102.3±17.4 g/L, respectively; 
all P<0.05, n=129; table 2). However, it has to be noted that 
the difference between mean venous and capillary Hb concen-
tration by Hemocue Hb301 was small but clinically significant. 
The prevalence of anaemia was 36.4%, 41.9% and 65.9%, 
respectively, in venous blood by Hemocue Hb301, capillary 
blood by Hemocue Hb301 and venous blood by automated 
analyser.
hb measurements provided by the three different hemoCue 
hb301 devices
In the analyses comparing the results of the three different 
HemoCue Hb301 devices for 29 venous blood samples (online 
supplementary table S3), mean Hb did not differ signifi-
cantly between HemoCue Hb301 #1 and #2 used in the 
field (112.9±8.8 g/L vs 113.2±6.9 g/L; P=0.96). However, 
mean Hb concentration obtained with HemoCue Hb 301 #3 
(117.1±9.4 g/L) was significantly higher than the mean Hb 
obtained with both HemoCue Hb301 #1 and #2. There was a 
good correlation among the three different HemoCue Hb301 
devices (r ranged from 0.62 to 0.89). However, based on the 
Bland-Altman plots, the agreement was good only between the 
HemoCue Hb301 #1 and #2 with a bias (95% limits of agree-
ment) of −0.28 (−8.23 to 7.68) g/L. We found a within-in-
strument variation (coefficient of variation (CV)) of 7.7%, 
6.1% and 8.0%, respectively, for HemoCue #1, #2 and #3.
Quality control results
Results from the quality control tests using Eurotrol HB301 
control solutions showed that the average concentration was 
74.0±3.0 g/L (CV=3.8%) and 131.0±3.0 g/L (CV=2.5%) for 
levels 1 and 2, respectively, which was within the acceptable 
range suggested by the manufacturer.
dIsCussIOn
In this study of almost 1500 young children, mean capillary Hb 
concentrations by HemoCue Hb301 were significantly higher 
compared with mean venous Hb concentrations determined 
by two automated haematology analysers (Sysmex XT-1800i 
and Mindray BC-3000Plus), resulting in a significantly lower 
anaemia prevalence by Hemocue (53.7% vs 73.9%). Possible 
Figure 1 Correlation of Hb concentrations assessed by 
Hemocue Hb301 and automated analysers combined (XT-1800i by 
Sysmex and BC-3000Plus by Mindray Medical International Ltd.) and 
concordance plots between the 2 methods. 
Figure 2 Bland-Altman plot showing agreement in haemoglobin 
concentration of young Laotian children assessed by HemoCue Hb301 
and two automated haematology analysers combined (XT-1800i by 
Sysmex and BC-3000Plus by Mindray Medical International).
Table 2 Paired comparisons of haemoglobin concentrations by 
HemoCue Hb301 (capillary and venous) and by Mindray BC-3000Plus 
in young Laotian children (n=129)
Comparisons
hb 
(mean±sd), 
g/l P*
bias (limits of 
agreement)
Anaemia 
prevalence 
n (%) P†
Capillary 
HemoCue
111.0±10.7 54 (41.9)
versus 0.03 −2.5 
(–4.8 to –0.2)
0.21
Venous HemoCue 113.6±14.0 47 (36.4)
Capillary 
HemoCue
111.0±10.7 54 (41.9)
versus <0.0001 8.7 
(6.0 to 11.4)
<0.0001
Venous automated 
analyser
102.3±17.4 85 (65.9)
Venous HemoCue 113.6±14.0 47 (36.4)
versus <0.0001 11.2 
(8.2 to 14.2)
<0.0001
Venous automated 
analyser
102.3±17.4 85 (65.9)
*P value for difference of mean Hb concentration.
†P value for anaemia prevalence.
Hb, haemoglobin.
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reasons for this difference are true physiological differences in 
Hb concentrations of venous versus capillary blood, differences 
in accuracy of the analytical instruments and differences in 
specimen collection and processing prior to analyses. To inves-
tigate whether this difference was due to the blood sampling 
site or the analytical instrument used, we also assessed capil-
lary and venous Hb by HemoCue Hb301 and compared these 
with venous Hb concentration by the Mindray BC-3000Plus 
in a substudy of 129 children and found that venous Hb 
levels were slightly higher than capillary Hb concentrations 
by HemoCue Hb301 and that both were substantially higher 
than venous Hb concentrations obtained with the Mindray 
BC-3000Plus automated haematology analyser, resulting in a 
significantly lower prevalence of anaemia when the HemoCue 
Hb301 device was used. Thus, regardless of the type of blood 
sample, HemoCue Hb301 showed a bias towards higher Hb 
concentrations compared with an automated haematology 
analyser.
The instruments used in our study performed well in quality 
control testing throughout the project. Moreover, the two 
HemoCue Hb301 devices (#1 and #2) used in the main anal-
yses yielded similar results and the third device (#3) with signifi-
cantly higher Hb concentrations was not used in any of the 
comparisons other than the device comparison for the present 
report. Thus, we trust that our findings derive from accurate 
and precise instruments. However, it has to be noted that the 
quality control solutions for Hemocue devises provided by 
Eurotrol (Burlington, Massachusetts, USA) consider a very wide 
range acceptable, thus not allowing to properly assess accuracy 
and precision of Hemocue devices. A reduction in acceptable 
range along with the possibility to adjust the Hemocue device 
should be reconsidered for future product developments of the 
Hemocue devices.
In contrast to our study, which found that venous Hb levels 
were slightly higher than capillary Hb concentrations using 
HemoCue Hb301, some previous studies have reported that 
capillary Hb by HemoCue was higher than venous Hb concen-
trations by HemoCue.26 36 The difference in Hb concentra-
tions between capillary and venous blood samples has been 
explained by the fact that a capillary blood drop reflects the 
content of blood from various loop capillaries and small arte-
rioles and venules, and a venous sample reflects the blood 
coursing through the veins, heart and arteries.26 A high with-
in-subject variability (biological variability) of capillary blood 
samples compared with venous blood has previously been 
documented.37 However, our study does not fully support 
this hypothesis because we also found that venous Hb levels 
determined by HemoCue Hb301 were higher than venous 
Hb concentrations determined by an automated haematology 
analyser, implying that the primary difference found in our 
study was due to the analytical method used. Nevertheless, we 
found a small but significant difference between capillary and 
venous Hb concentrations by HemoCue Hb301, which may 
be due to improper capillary sampling such as excessive finger 
squeezing or partial filling of the microcuvette.17
Our finding that capillary Hb concentrations by HemoCue 
Hb301 are significantly higher than venous Hb concentrations 
obtained with two different automated haematology analysers 
is consistent with some previous studies in pregnant women in 
Sudan19 and Brazil,36 blood donors in the USA26 and different 
population subgroups (preschool children, school children, 
pregnant women, non-pregnant women and men) in Ghana,25 
but not with studies in women with genetic Hb disorders in 
Cambodia,21 adults and children in Mexico,29 blood donors 
in Ireland38 and children in South Africa.30 Time and position 
during blood collection39 40 have been suggested to explain 
discrepancies between different devices and to influence the 
variability in Hb levels obtained by HemoCue. An additional 
source of error may be inadequate mixing of venous blood 
in the blood collection tube, which may lead to a reading of 
relatively more plasma rather than red blood cells by the auto-
mated analyser and would result in a lower Hb concentration. 
However, this may be less likely in our study since we found 
consistent results with automated haematology analysers run 
by different technicians based in two independent laborato-
ries. To minimise technical errors we emphasised the correct 
blood collection and processing for each analytical method 
during training and continued supervision.
Direct comparison of our findings with previous studies is 
complicated by several factors. First, we used the HemoCue 
Hb301, while other studies used either the HemoCue B-He-
moglobin or HemoCue Hb201, which employs different 
biochemical methods to determine Hb concentrations. In addi-
tion, we used Sysmex XT-1800i and Mindray BC-3000Plus 
automated analysers, whereas others used other instruments. 
Other factors that differ across studies are the study settings, 
the participants’ age range and ethnicity and whether Hb was 
assessed on fasting or non-fasting blood.41 Our study included 
very young children (age ranged from 6 to 32 months old), 
while other studies included older children (1–4 years old25 
or 6–8 years old30) and found HemoCue to be comparable 
with the Sysmex KX21N and the Siemens Advia 2120 anal-
ysers, respectively. Indeed, our results suggest that the age of 
the study population and the anaemia prevalence are poten-
tially important factors. Specifically, we found that the bias 
(difference between mean Hb concentrations using the two 
methods) is similar in 12-month to 17-month and 18-month 
to 24-month children, but significantly lower than that of 
children 6–11 months of age; potential explanations of this 
finding may be that the anaemia prevalence was higher in 
younger children or that blood collection may be more chal-
lenging among very young children. Another factor compli-
cating the comparison with other studies is represented by 
the range of Hb concentrations in the study population. In a 
study of over 36 000 paired capillary and venous samples of 
adult blood donors, venous Hb levels by automated haema-
tology analyser were consistently higher than capillary levels 
by HemoCue when the Hb concentrations were in the lower 
part of the normal non-anaemic range.38 Similarly, a study in 
Cambodian women with genetic Hb disorders reported that 
the HemoCue (HemoCue Hb 201+Hemocue AB) appears 
to underestimate Hb concentrations in capillary blood as 
compared with venous Hb by Sysmex at lower Hb concen-
trations and to overestimate Hb concentrations at higher Hb 
concentrations, resulting in false positives in the diagnosis of 
anaemia.21 This is in contrast to our study, which found that 
HemoCue Hb301 overestimated capillary Hb levels at lower 
Hb concentrations, resulting in a lower prevalence of anaemia.
As mentioned above, the two HemoCue Hb301 devices 
used in the field during enrolment and endline assessments 
provided comparable results, while a third back-up device 
yielded significantly different concentrations. Similarly, 
inconsistent measurements were found using 12 different 
HemoCue Hb301 devices in a methodological study of women 
in Cambodia.42 Further investigation is needed to deter-
mine inherent variability among different HemoCue Hb301 
devices, and results should be routinely compared when multi-
ples devices are deployed in a single study.
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One strength of this study is its large sample size, which 
allowed us to explore the agreement between methods by 
age group. In addition, we ran different sets of analyses to 
compare capillary and venous Hb using HemoCue Hb301, 
and we included regular quality control and a methodolog-
ical comparison of three individual HemoCue Hb301 devices 
owned by the project. Moreover, the capillary and venous 
blood draws occurred within a few minutes of each other for 
each child. This study also has some limitations. It has been 
suggested that the HemoCue device may be more accurate 
in Hb concentration determination than automated analy-
sers43 given that the latter requires a sample dilution, while 
HemoCue assesses Hb directly and is not affected by changes 
in turbidity. We were not able to confirm this statement as 
we did not assess Hb concentrations using the cyanmethemo-
globin method, which is considered the reference procedure 
by the International Committee for Standardization in Hema-
tology and WHO.10 We were also not able to compare the 
accuracy of the two automated haematology analysers against 
each other in the same sample of children because the respec-
tive subsamples were collected for different aspects of the Lao 
Zinc Study. It is worth mentioning that a WHO consultation 
on Hb assessment is ongoing and will likely shed new light 
on guidelines and recommendations for Hb assessment and 
interpretation.
COnClusIOn
To date, our study is the largest study comparing capillary 
Hb concentration assessed by HemoCue Hb301 with venous 
Hb concentrations determined by automated analysers in 
young children. Regardless of the type of blood sample, the 
HemoCue device showed poor agreement compared with 
two automated haematology analysers, resulting in signifi-
cantly different anaemia prevalences. The HemoCue is useful 
in many different settings and remains a widely used method 
in field settings as it has several advantages and is relatively 
inexpensive compared with automated haematology analysers. 
However, given the difference in anaemia prevalences found 
with the different methods, further research is needed to 
better understand potential sources of error in the Hb assess-
ment by HemoCue with the aim to better train phlebotomists 
and implement appropriate standardised procedures.
Take home messages
 ► The Hemocue Hb301 device showed poor agreement 
compared with two automated haematology analysers.
 ► Capillary haemoglobin (Hb) concentration by Hemocue Hb301 
was higher than venous Hb concentration by automated 
haematology analyser.
 ► Venous Hb concentration by Hemocue Hb301 was higher 
than capillary Hb concentration by Hemocue Hb301.
 ► Methodological differences resulted in a significantly lower 
anaemia prevalence by Hemocue.
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